2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole

INTERMEDIATES

CAT No.# CS-DT-00003
Category Intermediates
CAS 142384-07-4
Stock Status
AVAILABLE ENQUIRE NOW

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 316.34
Molecular Formula C14H12N4O3S
Synonyms: 2-(((3-methyl-4-nitropyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
Shipping: Free Shipping for worldwide on order above 2000 USD
2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Worldwide Suppliers of 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Intermediates Clearsynth CS-DT-00003

Product rating: 9 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole based on 20 ratings

  1. Intermediates
  2. 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Palbociclib N-Glucuronide
15. Carpropamid
16. Olmesartan N1-Trityl Impurity
17. 1-Octadecanethiol
18. H-Ser(Bzl)-OBzl p-tosylate (E-3755.0005)
19. 2-((benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene
20. α-Pinene oxide


This page contains information about 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Cas 142384-07-4 and its Intermediates.

2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Worldwide Suppliers of 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Intermediates Clearsynth 142384-07-4

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."